β Scribed by Nicola A. Foster; Anindo K. Banerjee; Jian Xian; Ian Roberts; Francesco Pezzella; Nicholas Coleman; Andrew G. Nicholson; Peter Goldstraw; Jeremy P. George; Pamela H. Rabbitts
No coin nor oath required. For personal study only.
Carcinomas are believed to develop by incremental steps of increasingly abnormal morphology driven by accumulating somatic genetic changes. This process is often difficult to study, as the early stages are undetectable. We used fluorescence bronchoscopy, which enhances detection of preinvasive bronchial lesions, and have obtained sequential biopsies of carcinoma in situ (CIS) from a patient with no detectable tumor and from a squamous cell carcinoma that developed 19 months after presentation at the site of one of the previous CIS lesions. Biopsies of preinvasive CIS, which followβup showed had different pathologic outcomes, and tumor were microdissected to obtain enriched cell populations and DNA prepared from them. Molecular characteristics of these biopsies were compared by loss of heterozygosity analysis, TP53 mutation analysis, and comparative genomic hybridization. Although all lesions examined had the same TP53 mutation and almost identical allelotypes, differences were observed. Loss in 5q21 and amplification of 3q25β26 were associated with the lesion that progressed and the subsequent carcinoma. Allele loss at 4p16 was detected in the tumor but not in any of the CIS lesions, suggesting it was a late event associated with tumor invasion. Amplification at 4q12 was specifically observed in the tumor and in the CIS at the site of eventual tumor formation. Although these findings may be unique to this one patient, the successful demonstration of sequential genetic changes raises the possibility that this approach, unencumbered by interpatient variability between lesions, will greatly facilitate the identification of molecular events driving the invasive process Β© 2005 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Background: Recent classifications identify four categories of neuroendocrine (ne) tumors of the lung: low grade typical carcinoid (tc), intermediate grade atypical carcinoid (ac), and high grade large cell neuroendocrine carcinoma (lc-nec) and small cell lung carcinoma (sclc). ## Methods: The
## Abstract The paxillin gene (__PXN__) encodes a focal adhesion associated protein that could be involved in the progression of lung cancer through its interactions with the actin cytoskeleton and key signal transduction oncogenes. __PXN__ mutations and __PXN__ amplifications were recently identif